Longitudinal Study of the Vascular Glycocalyx and Urinary Podocyte Markers During Pregnancy.

BACKGROUND

We aimed to assess the longitudinal changes of glycocalyx, a proteoglycan/glycoprotein layer that lines and protects endothelial cells in normotensive pregnancies (NPs); to correlate glycocalyx parameters with kidney injury markers (podocin-positive to nephrin-positive [P/N] ratio); and to explore changes in P/N ratio in preeclampsia.

METHODS

Plasma and urine samples and glycocalyx measurements using side-stream darkfield imaging were collected at each trimester from pregnant women (n=31). Plasma glycocalyx components were measured by ELISA, and urinary P/N-positive extracellular vesicles by flow cytometry.

RESULTS

In NPs (n=26), glycocalyx degradation increased from the first to the second trimester (P=0.008) and returned to first-trimester values in the third trimester (P=0.008). Microvascular perfusion decreased from the first to the second trimester (P=0.006) and increased back to first-trimester values by the third trimester (P=0.039). Plasma syndecan 1 level showed a steady increase from the first to the second trimester (P<0.001) and further in the third trimester (P<0.001); hyaluronic acid increased from the first to the second trimester (P=0.016) without further changes. Glycocalyx degradation was associated with an increase in P/N ratio from the first to the second trimester of NPs and remained stable through the third trimester. P/N ratio strongly correlated with elevated syndecan 1 and hyaluronic acid levels in the third trimester. Comparison of P/N ratios between NP and preeclampsia (n=5) showed higher values in preeclampsia across all trimesters (P=0.028).

CONCLUSIONS

Glycocalyx changes during NPs are associated with elevated urinary podocyte markers. Increase in P/N ratio across NPs, and further in preeclampsia, suggests that podocyte injury in preeclampsia is extension of physiological changes in pregnancy, which may predate its clinical presentation.